Torthaí cuardaigh - Turkington, Richard C
- 1 - 19 toradh as 19 á dtaispeáint
-
1
-
2
Cholethorax following Percutaneous Transhepatic Biliary Drainage de réir Turkington, Richard C, Leggett, Julian J, Hurwitz, Jane, Eatock, Martin M
Foilsithe / Cruthaithe 2007Téacs -
3
Exercise efficacy and prescription during treatment for pancreatic ductal adenocarcinoma: a systematic review de réir O’Connor, Dominic, Brown, Malcolm, Eatock, Martin, Turkington, Richard C., Prue, Gillian
Foilsithe / Cruthaithe 2021Téacs -
4
The Impact of the COVID-19 Pandemic on Barrett’s Esophagus and Esophagogastric Cancer de réir Turkington, Richard C., Lavery, Anita, Donnelly, David, Cairnduff, Victoria, McManus, Damian T., Coleman, Helen G.
Foilsithe / Cruthaithe 2021Téacs -
5
Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes de réir McGuigan, Andrew, Kelly, Paul, Turkington, Richard C, Jones, Claire, Coleman, Helen G, McCain, R Stephen
Foilsithe / Cruthaithe 2018Téacs -
6
Does risk of progression from Barrett’s esophagus to esophageal adenocarcinoma change based on the number of non-dysplastic endoscopies? de réir Kunzmann, Andrew T, Coleman, Helen G, Johnston, Brian T, Turkington, Richard C, McManus, Damian, Anderson, Lesley A, Thrift, Aaron P
Foilsithe / Cruthaithe 2020Téacs -
7
‘Missed’ oesophageal adenocarcinoma and high-grade dysplasia in Barrett’s oesophagus patients: A large population-based study de réir van Putten, Margreet, Johnston, Brian T, Murray, Liam J, Gavin, Anna T, McManus, Damian T, Bhat, Shivaram, Turkington, Richard C, Coleman, Helen G
Foilsithe / Cruthaithe 2017Téacs -
8
A DNA-damage immune response assay combined with PET biomarkers predicts response to neo-adjuvant chemotherapy and survival in oesophageal adenocarcinoma de réir Foley, Kieran G., Lavery, Anita, Napier, Eoin, Campbell, David, Eatock, Martin M., Kennedy, Richard D., Bradley, Kevin M., Turkington, Richard C.
Foilsithe / Cruthaithe 2021Téacs -
9
Immune cell infiltrates as prognostic biomarkers in pancreatic ductal adenocarcinoma: a systematic review and meta‐analysis de réir McGuigan, Andrew J, Coleman, Helen G, McCain, R Stephen, Kelly, Paul J, Johnston, David I, Taylor, Mark A, Turkington, Richard C
Foilsithe / Cruthaithe 2021Téacs -
10
Inequalities in the decline and recovery of pathological cancer diagnoses during the first six months of the COVID-19 pandemic: a population-based study de réir Hamilton, Ashleigh C., Donnelly, David W., Loughrey, Maurice B., Turkington, Richard C., Fox, Colin, Fitzpatrick, Deirdre, O’Neill, Ciaran E., Gavin, Anna T., Coleman, Helen G.
Foilsithe / Cruthaithe 2021Téacs -
11
Pharmacogenomic profiling and pathway analyses identify MAPK-dependent migration as an acute response to SN38 in p53 null and mutant colorectal cancer cells de réir Allen, Wendy L., Turkington, Richard C., Stevenson, Leanne, Carson, Gail, Coyle, Vicky M., Hector, Suzanne, Dunne, Philip, Van Schaeybroeck, Sandra, Longley, Daniel B., Johnston, Patrick G.
Foilsithe / Cruthaithe 2012Téacs -
12
Sex hormone receptor expression and survival in esophageal adenocarcinoma: a prospective cohort study de réir McMenamin, Úna C., Trainor, James, Coleman, Helen G., McManus, Damian T., McQuaid, Stephen, Bingham, Victoria, James, Jacqueline, Salto-Tellez, Manuel, Johnston, Brian T., Turkington, Richard C.
Foilsithe / Cruthaithe 2018Téacs -
13
Vitamin D receptor as a marker of prognosis in oesophageal adenocarcinoma: a prospective cohort study de réir McCain, Stephen, Trainor, James, McManus, Damian T., McMenamin, Úna C., McQuaid, Stephen, Bingham, Victoria, James, Jacqueline A., Salto-Tellez, Manuel, Turkington, Richard C., Coleman, Helen G.
Foilsithe / Cruthaithe 2018Téacs -
14
Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and cape... de réir Thomas, Anne, Virdee, Pradeep S., Eatock, Martin, Lord, Simon R., Falk, Stephen, Anthoney, D. Alan, Turkington, Richard C., Goff, Matthew, Elhussein, Leena, Collins, Linda, Love, Sharon, Moschandreas, Joanna, Middleton, Mark R.
Foilsithe / Cruthaithe 2020Téacs -
15
The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation de réir Humphries, Matthew P., Craig, Stephanie G., Kacprzyk, Rafal, Fisher, Natalie C., Bingham, Victoria, McQuaid, Stephen, Murray, Graeme I., McManus, Damian, Turkington, Richard C., James, Jacqueline, Salto-Tellez, Manuel
Foilsithe / Cruthaithe 2020Téacs -
16
Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study de réir McCain, R. Stephen, McManus, Damian T., McQuaid, Stephen, James, Jacqueline A., Salto-Tellez, Manuel, Reid, Nathan B., Craig, Stephanie, Chisambo, Chintapuza, Bingham, Victoria, McCarron, Eamon, Parkes, Eileen, Turkington, Richard C., Coleman, Helen G.
Foilsithe / Cruthaithe 2019Téacs -
17
Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma de réir Blayney, Jaine K., Cairns, Lauren, Li, Gerald, McCabe, Niamh, Stevenson, Leanne, Peters, Christopher J., Reid, Nathan B., Spence, Veronica J., Chisambo, Chintapuza, McManus, Damian, James, Jacqueline, McQuaid, Stephen, Craig, Stephanie, Arthur, Kenneth, McArt, Darragh, Ong, Chin-Ann J., Lao-Sirieix, Pierre, Hamilton, Peter, Salto-Tellez, Manuel, Eatock, Martin, Coleman, Helen G., Fitzgerald, Rebecca C., Kennedy, Richard D., Turkington, Richard C.
Foilsithe / Cruthaithe 2018Téacs -
18
Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological Evaluation de réir Saraswati, A. Prasanth, Relitti, Nicola, Brindisi, Margherita, Osko, Jeremy D., Chemi, Giulia, Federico, Stefano, Grillo, Alessandro, Brogi, Simone, McCabe, Niamh H., Turkington, Richard C., Ibrahim, Ola, O’Sullivan, Jeffrey, Lamponi, Stefania, Ghanim, Magda, Kelly, Vincent P., Zisterer, Daniela, Amet, Rebecca, Hannon Barroeta, Patricia, Vanni, Francesca, Ulivieri, Cristina, Herp, Daniel, Sarno, Federica, Di Costanzo, Antonella, Saccoccia, Fulvio, Ruberti, Giovina, Jung, Manfred, Altucci, Lucia, Gemma, Sandra, Butini, Stefania, Christianson, David W., Campiani, Giuseppe
Foilsithe / Cruthaithe 2020Téacs -
19
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma de réir Turkington, Richard C, Knight, Laura A, Blayney, Jaine K, Secrier, Maria, Douglas, Rosalie, Parkes, Eileen E, Sutton, Eilis K, Stevenson, Leanne, McManus, Damian, Halliday, Sophia, McCavigan, Andrena M, Logan, Gemma E, Walker, Steven M, Steele, Christopher J, Perner, Juliane, Bornschein, Jan, MacRae, Shona, Miremadi, Ahmad, McCarron, Eamon, McQuaid, Stephen, Arthur, Kenneth, James, Jacqueline A, Eatock, Martin M, O’Neill, Robert, Noble, Fergus, Underwood, Timothy J, Harkin, D Paul, Salto-Tellez, Manuel, Fitzgerald, Rebecca C, Kennedy, Richard D
Foilsithe / Cruthaithe 2019Téacs